- Report
- February 2024
- 94 Pages
Global
From €3500EUR$3,967USD£3,078GBP
Polymyxin B is an antibiotic used to treat a variety of bacterial infections. It is a polypeptide antibiotic derived from the bacterium Bacillus polymyxa. It is used to treat infections caused by Gram-negative bacteria, such as Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa. Polymyxin B is often used in combination with other antibiotics to treat more serious infections. It is available in both injectable and topical forms.
Polymyxin B is used in both human and veterinary medicine. It is used to treat a variety of infections, including urinary tract infections, skin and soft tissue infections, and respiratory tract infections. It is also used to treat infections caused by multi-drug resistant bacteria.
Polymyxin B is available in a variety of formulations, including tablets, capsules, and injectable solutions. It is also available as a topical ointment or cream.
Some companies in the Polymyxin B market include Pfizer, Merck, Sanofi, and Bayer. Show Less Read more